about
Modes of resistance to anti-angiogenic therapyAntiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasisPericyte-targeting drug delivery and tissue engineeringAnti-angiogenesis and metastasis: a tumour and stromal cell allianceTumor endothelial cellsMedulloblastoma-biology and microenvironment: a reviewMouse models for studying angiogenesis and lymphangiogenesis in cancerSelective alpha-particle mediated depletion of tumor vasculature with vascular normalizationFibroblast Growth Factor 9 Imparts Hierarchy and Vasoreactivity to the Microcirculation of Renal Tumors and Suppresses MetastasesP-Rex1 cooperates with PDGFRβ to drive cellular migration in 3D microenvironmentsPericytes, an overlooked player in vascular pathobiologyAttenuated transforming growth factor beta signaling promotes metastasis in a model of HER2 mammary carcinogenesisPI3K at the crossroads of tumor angiogenesis signaling pathways(3)D [corrected] quantification of tumor vasculature in lymphoma xenografts in NOD/SCID mice allows to detect differences among vascular-targeted therapiesDeletion of cathepsin H perturbs angiogenic switching, vascularization and growth of tumors in a mouse model of pancreatic islet cell cancerN-CAM exhibits a regulatory function in pathological angiogenesis in oxygen induced retinopathyMicroenvironmental regulation of metastasisRole of platelet-derived growth factors in physiology and medicineXenotropic MLV envelope proteins induce tumor cells to secrete factors that promote the formation of immature blood vessels.Vascular normalization as a therapeutic strategy for malignant and nonmalignant disease.Normalization of the vasculature for treatment of cancer and other diseases.Tumors as organs: complex tissues that interface with the entire organismNetrin-4 promotes mural cell adhesion and recruitment to endothelial cells.Targeting PDGF signaling in carcinoma-associated fibroblasts controls cervical cancer in mouse modelMesenchymal stem cells in early entry of breast cancer into bone marrow.Bone marrow multipotent mesenchymal stroma cells act as pericyte-like migratory vehicles in experimental gliomasToward brain tumor gene therapy using multipotent mesenchymal stromal cell vectors.Lack of host SPARC enhances vascular function and tumor spread in an orthotopic murine model of pancreatic carcinoma.Regulation of endothelial Fas expression as a mechanism of promotion of vascular integrity by mural cells in tumors.Anti-angiogenic therapy for cancer: current progress, unresolved questions and future directions.Angiogenesis - still a worthwhile target for breast cancer therapy?Activation of the Wnt/planar cell polarity pathway is required for pericyte recruitment during pulmonary angiogenesis.Enhanced cancer metastasis in mice deficient in vasohibin-1 gene.Adult mesenchymal stem cells and women's health.MT-MMPS as Regulators of Vessel Stability Associated with AngiogenesisLoss of PDGF-B activity increases hepatic vascular permeability and enhances insulin sensitivity.Macrophages and cathepsin proteases blunt chemotherapeutic response in breast cancer.Distinct roles of vascular endothelial growth factor-D in lymphangiogenesis and metastasis.Increased tumor cell dissemination and cellular senescence in the absence of beta1-integrin function.Membrane-type 4 matrix metalloproteinase (MT4-MMP) induces lung metastasis by alteration of primary breast tumour vascular architecture.
P2860
Q24608005-D129CFF4-B5DA-4075-808F-803D2667D777Q24608039-9DF0D731-93FA-47CE-8891-FFA3B987DC24Q26745598-411AF41D-13F9-426F-B641-4A14C5034067Q26862741-204212E9-6725-4692-9F3A-D051CBA0486AQ26995733-C510BA53-83C3-40FE-A59C-190472F97B74Q26995823-81A559E6-FE1B-4782-AB03-3874D7DABA8FQ27003898-6010D41F-990D-4051-9D11-D0556AF84E45Q27303072-4923DDAC-D6BD-42A8-AA12-3C752AED8E1EQ27312628-619EC98F-D7AB-4685-BE03-9FBD411CF80EQ27320507-8ABCE733-5021-4752-9CC1-BFE3402051D3Q28070053-C586C231-0EF0-440F-9584-95B43709F32CQ28386225-F1A2D195-0C05-42D3-82EC-0A43C091C5C5Q28396795-CC759728-191E-4E1A-A2B0-C7906AC12914Q28488869-6B4DCFBF-7240-481C-B5A8-D6C6DB35FB22Q28505630-C7EE5EF5-BA22-4807-B3DA-3FBACB57DDC5Q28743741-4EF2CE3C-B14B-4D5A-B9AB-A1656537A54CQ29547660-A6A8C8B8-B828-416C-9A80-37EF7DBDC90EQ29615222-E5ACD1ED-EF64-4B39-8D90-E11C387615A7Q30418789-F5E011B4-B191-438E-9523-ECB9A45D9B9EQ30469815-CCB93AFE-7366-45B7-B084-6506537F5635Q30471456-05071D15-028D-4CDD-AD04-FA90488C2F0AQ30495528-4A264CAF-0ABF-4500-88F7-6B4700D939F1Q30570375-C2ECD130-B858-4621-9CD4-7D6F7E222664Q33317350-77521023-FDF3-4B2A-A0F2-A536570A6050Q33346309-3A345E57-F717-4638-8E4E-E50AE8B37E76Q33382708-0F3D0504-D4E4-41A9-A883-8E8974F48C24Q33560685-322C180A-7018-4192-BF9A-99D2D2CDF488Q33592374-DBFD8920-1216-4D3B-BC4C-1C352DF32B14Q33738744-047EF8AA-B92C-4AD1-B109-7CAC8366FF90Q33770680-3C17E392-7D9A-4AAB-8D1C-93732D79BCA6Q34423550-DEA5743F-1CAA-47C5-B31E-28FCA5B116BFQ34780828-338D27D7-8B8C-4CA7-AE9E-F8AA7AF2125DQ34997149-3E502332-DE9F-438E-81DC-070FED368B38Q35020032-EA89DDF3-9273-4F13-8BAA-D5DCE10AD681Q35025845-830A2E1A-97FE-42B4-9263-1B365BB7AB2DQ35216708-15DDC2B6-7F3C-45B9-A5BB-AF75174F9B28Q35624725-C1CA7776-C1A7-496F-9576-ABBDC4ACEA84Q35691635-E37F94C4-5908-43FE-84A0-22E726541583Q35846812-6E4BA557-6D85-42D2-9EFF-B04D39607593Q35893461-0E3762F8-5C10-46D0-83CE-B6B7A048CE29
P2860
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Pericytes limit tumor cell metastasis.
@en
type
label
Pericytes limit tumor cell metastasis.
@en
prefLabel
Pericytes limit tumor cell metastasis.
@en
P2093
P2860
P356
P1476
Pericytes limit tumor cell metastasis.
@en
P2093
Anders Ståhlberg
Henrik Semb
Holger Gerhardt
Joakim Håkansson
Per Lindblom
Xiaojie Xian
P2860
P304
P356
10.1172/JCI25705
P407
P577
2006-02-09T00:00:00Z